LLYZ was created on 2025-09-02 by Defiance. The fund's investment portfolio concentrates primarily on health care equity. LLYZ seeks to deliver 2x inverse leveraged exposure to the daily share price movement of Eli Lilly and Company (NASDAQ: LLY), less fees and expenses, through derivatives like swap agreements.